Gufic Biosciences profit decreased 32.76% in (Q4) FY 2019-20

Source

Team Infinities:

Gufic Biosciences Limited NSE Symbol:GUFICBIO, BSE Security Code:509079 has declared its 4th(fourth) quarter audited Standalone financial report from the month of January, 2020 to the month of March, 2020; for the fiscal year 2019-20.

Revenue Reported by Gufic Biosciences Limited for Fourth Quarter FY, 2019-20
Current Quarter (January, 2020 - March, 2020) Previous Quarter (October, 2019 - December, 2019) Corresponding Quarter (January, 2019 - March, 2019) 12 Months Ended (April, 2019 - March, 2020) Corresponding 12 Months Ended (April, 2018 - March, 2019)
82.72 100.80 94.83 364.57 354.94
Calculated Revenue of Gufic Biosciences Limited for Fourth Quarter FY, 2019-20
Current(March, 2020) VS Previous(December, 2019) Current(March, 2020) VS Corresponding(March, 2019) 12 months Ended(April, 2019 - March, 2020) VS Corresponding 12 months Ended(April, 2018 - March, 2019)
Change Change % Change Change % Change Change %
18.08 17.94%(Revenue Decrease) 12.11 12.77%(Revenue Decrease) 9.63 2.71%(Revenue Increase)

Revenue: Gufic Biosciences Limited's financial report shows that the company's revenue decreased by 17.94% in QoQ(Quarter on Quarter) / current quarter(January, 2020 - March, 2020) for revenue decrease of Rs.18.08 crores, as the company posted revenue of Rs.82.72 crores; in compare to previous quarter(October, 2019 - December, 2019) when the company reported revenue of Rs.100.80 crores.
The result also shows that the company's revenue decreased by 12.77% in YoY(Year over Year) / in current quarter(January, 2020 - March, 2020) for revenue decrease of Rs.12.11 crores; in compare to corresponding quarter(January, 2019 - March, 2019) when the company posted revenue of Rs.94.83 crores.
The company also reported that its revenue increased by 2.71% in 12 months end(April, 2019 - March, 2020) for revenue increase of Rs.9.63 crores, since the company reported revenue of Rs.364.57 crores; in compare to corresponding 12 months end(April, 2018 - March. 2019) when the company posted revenue of Rs.354.94 crores.

Gross Margin(%) Reported by Gufic Biosciences Limited for Fourth Quarter FY, 2019-20
Current Quarter (January, 2020 - March, 2020) Previous Quarter (October, 2019 - December, 2019) Corresponding Quarter (January, 2019 - March, 2019) 12 Months Ended (April, 2019 - March, 2020) Corresponding 12 Months Ended (April, 2018 - March, 2019)
49.11 21.78 84.87 43.27 56.32
Calculated Gross Margin(%) of Gufic Biosciences Limited for Fourth Quarter FY, 2019-20
Current(March, 2020) VS Previous(December, 2019) Current(March, 2020) VS Corresponding(March, 2019) 12 months Ended(April, 2019 - March, 2020) VS Corresponding 12 months Ended(April, 2018 - March, 2019)
Change Change % Change Change % Change Change %
27.34 125.53%(GM Increase) 35.76 42.13%(GM Decrease) 13.04 23.16%(GM Decrease)

Gross Margin(%)/ GM: The company's financial report indicates, the company's GM increased by 125.53% in QoQ(Quarter on Quarter) / current quarter(January, 2020 - March, 2020) for 27.34% GM increase, as the company reported 49.11% GM; in compare to previous quarter(October, 2019 - December, 2019) when the company reported 21.78% GM.
The result also indicates, the company's GM decreased by 42.13% in YoY(Year over Year) / in current quarter(January, 2020 - March, 2020) for 35.76% GM decrease; in compare to corresponding quarter(January, 2019 - March, 2019) when the company reported 84.87% GM.
The company also reported that its GM decreased by 23.16% in 12 months end(April, 2019 - March, 2020) for 13.04% GM decrease, since the company reported 43.27% GM; in compare to corresponding 12 months end(April, 2018 - March. 2019) when the company reported 56.32% GM.

EBITDA Reported by Gufic Biosciences Limited for Fourth Quarter FY, 2019-20
Current Quarter (January, 2020 - March, 2020) Previous Quarter (October, 2019 - December, 2019) Corresponding Quarter (January, 2019 - March, 2019) 12 Months Ended (April, 2019 - March, 2020) Corresponding 12 Months Ended (April, 2018 - March, 2019)
11.45 14.98 15.80 51.40 50.16
Calculated EBITDA of Gufic Biosciences Limited for Fourth Quarter FY, 2019-20
Current(March, 2020) VS Previous(December, 2019) Current(March, 2020) VS Corresponding(March, 2019) 12 months Ended(April, 2019 - March, 2020) VS Corresponding 12 months Ended(April, 2018 - March, 2019)
Change Change % Change Change % Change Change %
3.53 23.56%(EBITDA Decrease) 4.35 27.53%(EBITDA Decrease) 1.24 2.47%(EBITDA Increase)

EBITDA/ Earnings before interest, tax, depreciation and amortization: The company's financial report shows that the company's EBITDA decreased by 23.56% in QoQ(Quarter on Quarter) / current quarter(January, 2020 - March, 2020) for EBITDA decrease of Rs.3.53 crores, as the company posted EBITDA of Rs.11.45 crores; in compare to previous quarter(October, 2019 - December, 2019) when the company reported EBITDA of Rs.14.98 crores.
The result also shows that the company's EBITDA decreased by 27.53% in YoY(Year over Year) / in current quarter(January, 2020 - March, 2020) for EBITDA decrease of Rs.4.35 crores; in compare to corresponding quarter(January, 2019 - March, 2019) when the company posted EBITDA of Rs.15.80 crores.
The company also reported that its EBITDA increased by 2.47% in 12 months end(April, 2019 - March, 2020) for EBITDA increase of Rs.1.24 crores, since the company reported EBITDA of Rs.51.40 crores; in compare to corresponding 12 months end(April, 2018 - March. 2019) when the company posted EBITDA of Rs.50.16 crores.

Profit and Loss Reported by Gufic Biosciences Limited for Fourth Quarter FY, 2019-20
Current Quarter (January, 2020 - March, 2020) Previous Quarter (October, 2019 - December, 2019) Corresponding Quarter (January, 2019 - March, 2019) 12 Months Ended (April, 2019 - March, 2020) Corresponding 12 Months Ended (April, 2018 - March, 2019)
4.72(Profit ) 7.02(Profit ) 6.01(Profit ) 22.86(Profit ) 21.94(Profit )
Calculated Profit and Loss of Gufic Biosciences Limited for Fourth Quarter FY, 2019-20
Current(March, 2020) VS Previous(December, 2019) Current(March, 2020) VS Corresponding(March, 2019) 12 months Ended(April, 2019 - March, 2020) VS Corresponding 12 months Ended(April, 2018 - March, 2019)
Change Change % Change Change % Change Change %
2.30 32.76%(Profit Decrease) 1.29 21.46%(Profit Decrease) 0.92 4.19%(Profit Increase)

Profit and Loss / PAT(Profit after Tax): The company's financial report shows that the company's profit decreased by 32.76% in QoQ(Quarter on Quarter) / current quarter(January, 2020 - March, 2020) for profit decrease of Rs.2.30 crores, as the company posted profit of Rs.4.72 crores; in compare to previous quarter(October, 2019 - December, 2019) when the company reported profit of Rs.7.02 crores.
The result also shows that the company's profit decreased by 21.46% in YoY(Year over Year) / in current quarter(January, 2020 - March, 2020) for profit decrease of Rs.1.29 crores; in compare to corresponding quarter(January, 2019 - March, 2019) when the company posted profit of Rs.6.01 crores.
The company also reported that its profit increased by 4.19% in 12 months end(April, 2019 - March, 2020) for profit increase of Rs.0.92 crore, since the company reported profit of Rs.22.86 crores; in compare to corresponding 12 months end(April, 2018 - March. 2019) when the company posted profit of Rs.21.94 crores.

EPS Reported by Gufic Biosciences Limited for Fourth Quarter FY, 2019-20
Current Quarter (January, 2020 - March, 2020) Previous Quarter (October, 2019 - December, 2019) Corresponding Quarter (January, 2019 - March, 2019) 12 Months Ended (April, 2019 - March, 2020) Corresponding 12 Months Ended (April, 2018 - March, 2019)
0.61 0.90 0.77 2.94 2.84
Calculated EPS of Gufic Biosciences Limited for Fourth Quarter FY, 2019-20
Current(March, 2020) VS Previous(December, 2019) Current(March, 2020) VS Corresponding(March, 2019) 12 months Ended(April, 2019 - March, 2020) VS Corresponding 12 months Ended(April, 2018 - March, 2019)
Change Change % Change Change % Change Change %
0.29 32.22%(EPS Decrease) 0.16 20.78%(EPS Decrease) 0.10 3.52%(EPS Increase)

EPS /Earning per Share: The company's financial report shows that the company's EPS decreased by 32.22% in QoQ(Quarter on Quarter) / current quarter(January, 2020 - March, 2020) for EPS decrease of Rs.0.29, as the company posted EPS of Rs.0.61; in compare to previous quarter(October, 2019 - December, 2019) when the company reported EPS of Rs.0.90.
The result also shows that the company's EPS decreased by 20.78% in YoY(Year over Year) / in current quarter(January, 2020 - March, 2020) for EPS decrease of Rs.0.16; in compare to corresponding quarter(January, 2019 - March, 2019) when the company posted EPS of Rs.0.77.
The company also reported that its EPS increased by 3.52% in 12 months end(April, 2019 - March, 2020) for EPS increase of Rs.0.10, since the company reported EPS of Rs.2.94; in compare to corresponding 12 months end(April, 2018 - March. 2019) when the company posted EPS of Rs.2.84.

Assets Reported by Gufic Biosciences Limited for Fourth Quarter FY, 2019-20
Details Non-current Assets Current Assets
Current Year Ended(March, 2020) Previous Year End(March, 2019) Current Year Ended(March, 2020) Previous Year End(March, 2019)
Reported 92.76 47.03 263.48 232.51
  Change Change % Change Change %
Calculated 45.73 97.24%(Assets Increase) 30.97 13.32%(Assets Increase)

Assets:The company reported its non-current assets increased by 97.24% in current year end(March, 2020) for non-current assets increase of Rs.45.73 crores, since the company reported net non-current assets of Rs.92.76 crores; in compare to previous year end(March, 2019) when the company reported net non-current assets of Rs.47.03 crores.
The balance sheet of the company also shows that, its current assets increased by 13.32% in current year end(March, 2020) for current assets increase of Rs.30.97 crores, as the company reported net current assets of Rs.263.48 crores; against previous year end(March, 2019) when the company reported net current assets of Rs.232.51 crores.

Liabilities Reported by Gufic Biosciences Limited for Fourth Quarter FY, 2019-20
Details Non-current Liabilities Current Liabilities
Current Year Ended(March, 2020) Previous Year End(March, 2019) Current Year Ended(March, 2020) Previous Year End(March, 2019)
Reported 35.82 17.85 224.57 186.34
  Change Change % Change Change %
Calculated 17.97 100.67%(Liabilities Increase) 38.23 20.52%(Liabilities Increase)

Liabilities:The company reported its non-current liabilities increased by 100.67% in current year end(March, 2020) for non-current liabilities increase of Rs.17.97 crores, since the company reported net non-current liabilities of Rs.35.82 crores; in compare to previous year end(March, 2019) when the company reported net non-current liabilities of Rs.17.85 crores.
The balance sheet of the company also shows that, its current liabilities increased by 20.52% in current year end(March, 2020) for current liabilities increase of Rs.38.23 crores, as the company reported net current liabilities of Rs.224.57 crores; against previous year end(March, 2019) when the company reported net current liabilities of Rs.186.34 crores.

 


***All amounts are given in Crore Indian Rupees(INR) except EPS (Earnings per share) which are in Indian Rupees(INR) only.***
Gross Margin=Total Revenue from Operations -(Cost of Materials Consumed + Purchases of stock-in-trade - Changes in inventories of finished goods, work-in-progress and stock-in-trade).
Gross Margin%=(Gross Margin / Total Revenue from Operations)*100.
EBITDA=Commission/Interest + Depreciation and Amortization + Tax + Profit/Loss (PAT).
1 Lac = 100,000.
1 Million = 10 Lacs.
1 Crore = 10 Millions.
1 Crore = 100 Lacs.
1 Billion = 1000 Millions.
1 Billion = 100 Crores.